Weisser J
Pädiatrische/neuropädiatrische Abteilung, Rehabilitationsklinik für Kinder und Jugendliche, Neckargemünd.
Klin Padiatr. 1988 Sep-Oct;200(5):375-9. doi: 10.1055/s-2008-1033736.
Short presentation of the common procedures to avoid transmission of human-immunodeficiency-virus (HIV) by hemoderivates especially clotting-factor-preparations. The stepwise seroconversion (ELISA, IFT, Western-blot) of HIV is shown in a 7 5/12 ys old boy with hemophilia A after administration of a dry-heated factor VIII-preparation. Seven similar observations were reported in the literature. On the other hand HIV-seroconversion could not be observed during treatment with wet-heated factor VIII-preparations. In consequence only wet-heated factor VIII-preparations and factor IX-preparations respectively should be administered to hemophiliacs without HIV-antibodies. By this precaution transmission of non-A, non-B-hepatitis may be avoided simultaneously.
关于通过血液制品尤其是凝血因子制剂避免人类免疫缺陷病毒(HIV)传播的常见程序的简短介绍。在一名7又5/12岁的甲型血友病男孩接受干热灭活的凝血因子VIII制剂治疗后,展示了HIV逐步血清转化(酶联免疫吸附测定、免疫荧光试验、免疫印迹法)的情况。文献中报道了另外7例类似观察结果。另一方面,在用湿热灭活的凝血因子VIII制剂治疗期间未观察到HIV血清转化。因此,对于没有HIV抗体的血友病患者,仅应分别给予湿热灭活的凝血因子VIII制剂和凝血因子IX制剂。通过这一预防措施,同时可避免非甲非乙型肝炎的传播。